Yüklüyor......
Secondary prevention of recurrence by interferon therapy after ablation therapy for hepatocellular carcinoma in chronic hepatitis C patients
Chronic hepatitis C is a leading cause of hepatocellular carcinoma (HCC) worldwide. Interferon (IFN) therapy decreases the incidence of HCC in patients with chronic hepatitis C. Prevention of chronic-hepatitis-C-related HCC is one of the most important issues in current hepatology. We have previousl...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
The WJG Press and Baishideng
2008
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2761574/ https://ncbi.nlm.nih.gov/pubmed/18985803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.14.6140 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|